Company News
Glenmark Launches Olanzapine Injection in US Market
Glenmark Pharmaceuticals launches Olanzapine for Injection, 10 mg/vial in US market through subsidiary Glenmark Pharmaceuticals Inc., USA.
The product is bioequivalent to Zyprexa IntraMuscular Injecti
